Detalhe da pesquisa
1.
Host restriction of Escherichia coli recurrent urinary tract infection occurs in a bacterial strain-specific manner.
PLoS Pathog
; 14(12): e1007457, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30543708
2.
Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
Proc Natl Acad Sci U S A
; 112(8): E871-80, 2015 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-25675528
3.
Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.
PLoS Pathog
; 11(1): e1004599, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25569799
4.
Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection.
PLoS Pathog
; 11(4): e1004818, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25927232
5.
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.
Curr Opin Infect Dis
; 28(1): 97-105, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25517222
6.
A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.
J Infect Dis
; 208(6): 921-8, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23737602
7.
Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.
mBio
; 15(2): e0255423, 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38270443
8.
Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections.
Infect Immun
; 81(1): 329-39, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23132492
9.
Secretory Leukocyte Protease Inhibitor Protects Against Severe Urinary Tract Infection in Mice.
bioRxiv
; 2023 Oct 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37873489
10.
Uropathogenic Escherichia coli infection-induced epithelial trained immunity impacts urinary tract disease outcome.
Nat Microbiol
; 8(5): 875-888, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37037942
11.
Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.
Infect Immun
; 80(8): 2826-34, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22665375
12.
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.
PLoS Pathog
; 6(8): e1001042, 2010 Aug 12.
Artigo
Inglês
| MEDLINE | ID: mdl-20811584
13.
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.
Nat Microbiol
; 7(5): 630-639, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35505248
14.
Mucosal infection rewires TNFÉ signaling dynamics to skew susceptibility to recurrence.
Elife
; 82019 08 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31429405
15.
Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.
Expert Opin Drug Discov
; 12(7): 711-731, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28506090
16.
Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions.
Sci Adv
; 3(2): e1601944, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28246638
17.
Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.
Sci Transl Med
; 9(382)2017 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-28330863
18.
A Murine Model for Escherichia coli Urinary Tract Infection.
Methods Mol Biol
; 1333: 159-75, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26468108
19.
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.
Microbiol Spectr
; 4(1)2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26999391
20.
A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease.
Nat Microbiol
; 2: 16196, 2016 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-27798558